Opinion: A new important study supports wider use of the polypill

Richard Smith: A new important study supports wider use of the polypill – The Lancet

Original study and commentaries: Randomized trial: A polypill comprising statins, multiple blood pressure lowering drugs, and aspirin prevents cardiovascular events among patients at intermediate cardiovascular risk

Commentary on Twitter

"We seem now to have good evidence that the polypill can reduce cardiovascular events and deaths by at least a third and probably by half in those who take the polypill regularly" @Richard56 discusses a new study in @NEJM https://t.co/B2tkN4pkDP

— The BMJ (@bmj_latest) November 17, 2020